Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Director departure
|
Pasithea Therapeutics Corp.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/06/2023 |
4
| STEINMAN LAWRENCE (Director) has filed a Form 4 on Pasithea Therapeutics Corp.
Txns:
| Bought 30,000 shares
@ $0.431, valued at
$12.9k
|
|
11/28/2022 |
4
| STEINMAN LAWRENCE (Director) has filed a Form 4 on Pasithea Therapeutics Corp.
Txns:
| Granted 5,000 shares
@ $0.98, valued at
$4.9k
|
|
11/28/2022 |
4
| Marques Tiago (CEO) has filed a Form 4 on Pasithea Therapeutics Corp.
Txns:
| Granted 5,000 shares
@ $1, valued at
$5k
Granted 1,000 shares
@ $1.03, valued at
$1k
Granted 1,206 shares
@ $1.02, valued at
$1.2k
Granted 2,000 shares
@ $1.03, valued at
$2.1k
|
|
11/22/2022 |
4
| STEINMAN LAWRENCE (Director) has filed a Form 4 on Pasithea Therapeutics Corp.
Txns:
| Granted 5,000 shares
@ $0.99, valued at
$5k
|
|
11/17/2022 |
4
| Dumesnil Simon (Director) has filed a Form 4 on Pasithea Therapeutics Corp.
Txns:
| Granted 10,000 shares
@ $1.07, valued at
$10.7k
Granted 40,000 shares
@ $1.06, valued at
$42.4k
Granted 100,000 options to buy
@ $6, valued at
$600k
|
|
10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/17/2022 |
4
| STEINMAN LAWRENCE (Director) has filed a Form 4 on Pasithea Therapeutics Corp.
Txns:
| Granted 1,000 shares
@ $1.14, valued at
$1.1k
Granted 9,000 shares
@ $1.13, valued at
$10.2k
|
|
10/12/2022 |
4
| Schneiderman Daniel H (CFO) has filed a Form 4 on Pasithea Therapeutics Corp.
Txns:
| Granted 300,000 options to buy
@ $1.26, valued at
$378k
|
|
09/30/2022 |
4
| Shahinian Eric (Member of 10% owner group) has filed a Form 4 on Pasithea Therapeutics Corp.
Txns:
| Bought 57,647 shares
@ $1.189, valued at
$68.5k
Bought 6,710 shares
@ $1.156, valued at
$7.8k
|
|
09/06/2022 |
4
| Shahinian Eric (Member of 10% owner group) has filed a Form 4 on Pasithea Therapeutics Corp.
Txns:
| Bought 55,646 shares
@ $1.1255, valued at
$62.6k
Bought 11,507 shares
@ $1.1389, valued at
$13.1k
Bought 21,748 shares
@ $1.1326, valued at
$24.6k
|
|
08/31/2022 |
4
| Shahinian Eric (Member of 10% owner group) has filed a Form 4 on Pasithea Therapeutics Corp.
Txns:
| Bought 5,000 shares
@ $1.1681, valued at
$5.8k
Bought 17,828 shares
@ $1.1472, valued at
$20.5k
|
|
08/26/2022 |
4
| Geller Avi (Member of 10% owner group) has filed a Form 4 on Pasithea Therapeutics Corp.
Txns:
| Bought 54,644 shares
@ $1.2982, valued at
$70.9k
|
|
08/18/2022 |
4
| Shahinian Eric (Member of 10% owner group) has filed a Form 4 on Pasithea Therapeutics Corp.
Txns:
| Bought 155,773 shares
@ $1.2087, valued at
$188.3k
|
|
06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/23/2022 |
4
| Marques Tiago (CEO) has filed a Form 4 on Pasithea Therapeutics Corp.
Txns:
| Granted 2,900 shares
@ $0.993, valued at
$2.9k
Granted 200 shares
@ $0.982, valued at
$196.4 Granted 100 shares
@ $0.988, valued at
$98.8 Granted 1,800 shares
@ $0.994, valued at
$1.8k
|
|
06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|